🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
This clinical study is in subjects who are 18 years old or older with local...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-04-21
Trial ID
NCT02301143
Treatments Being Tested
We want to compare Taxol given weekly with Taxotere given every 3 week both...
Status
Completed
Location
Ullevål university hospital
Start Date
2005-03
Trial ID
NCT00201435
The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Status
Completed
Location
Scottsdale Healthcare
Start Date
2006-08
Trial ID
NCT00307047
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
This study is divided into 5 arms: 1. Randomized Clinical Trial (RCT): Pro...
Status
Completed
Location
Baptist Medical Center Princeton
Start Date
2005-06
Trial ID
NCT00180479
Doctors leading this study hope to learn about the safety and effectiveness...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2022-08-22
Trial ID
NCT05108870
Treatments Being Tested
RATIONALE: Paclitaxel is one of the most widely used human anticancer agent...
Status
Completed
Location
Gomel Regional Clincial Oncology Center
Start Date
2009-02
Trial ID
NCT00989131
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215